vs

Side-by-side financial comparison of Arcturus Therapeutics Holdings Inc. (ARCT) and Canterbury Park Holding Corp (CPHC). Click either name above to swap in a different company.

Canterbury Park Holding Corp is the larger business by last-quarter revenue ($12.4M vs $7.2M, roughly 1.7× Arcturus Therapeutics Holdings Inc.). On growth, Canterbury Park Holding Corp posted the faster year-over-year revenue change (3.9% vs -68.4%). Canterbury Park Holding Corp produced more free cash flow last quarter ($-611.3K vs $-74.5M). Over the past eight quarters, Canterbury Park Holding Corp's revenue compounded faster (-6.0% CAGR vs -56.5%).

Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA (siRNA), messenger RNA (mRNA), gene editing RNA, DNA, antisense oligonucleotides, and microRNA.

Canterbury Park, is a horse racing track in Shakopee, Minnesota, United States. Canterbury Park Holding Corporation hosts parimutuel wagering on live thoroughbred and quarter horse racing at its facilities in Shakopee and parimutuel wagering on races held at out-of-state racetracks that are simulcast to the racetrack. In addition, the Canterbury Park Card Casino operates 24 hours a day, seven days a week, and is also regulated by the Minnesota Racing Commission. Casino games include blackjack...

ARCT vs CPHC — Head-to-Head

Bigger by revenue
CPHC
CPHC
1.7× larger
CPHC
$12.4M
$7.2M
ARCT
Growing faster (revenue YoY)
CPHC
CPHC
+72.3% gap
CPHC
3.9%
-68.4%
ARCT
More free cash flow
CPHC
CPHC
$73.9M more FCF
CPHC
$-611.3K
$-74.5M
ARCT
Faster 2-yr revenue CAGR
CPHC
CPHC
Annualised
CPHC
-6.0%
-56.5%
ARCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARCT
ARCT
CPHC
CPHC
Revenue
$7.2M
$12.4M
Net Profit
$-390.1K
Gross Margin
Operating Margin
2.6%
Net Margin
-3.1%
Revenue YoY
-68.4%
3.9%
Net Profit YoY
3.1%
68.7%
EPS (diluted)
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARCT
ARCT
CPHC
CPHC
Q4 25
$7.2M
$12.4M
Q3 25
$17.2M
$18.3M
Q2 25
$28.3M
$15.7M
Q1 25
$29.4M
$13.1M
Q4 24
$22.8M
$12.0M
Q3 24
$41.7M
$19.3M
Q2 24
$49.9M
$16.2M
Q1 24
$38.0M
$14.1M
Net Profit
ARCT
ARCT
CPHC
CPHC
Q4 25
$-390.1K
Q3 25
$-13.4M
$487.3K
Q2 25
$-9.2M
$-327.4K
Q1 25
$-14.1M
$-299.2K
Q4 24
$-30.0M
$-1.2M
Q3 24
$-6.9M
$2.0M
Q2 24
$-17.2M
$338.3K
Q1 24
$-26.8M
$998.2K
Operating Margin
ARCT
ARCT
CPHC
CPHC
Q4 25
2.6%
Q3 25
-96.3%
5.7%
Q2 25
-41.0%
2.8%
Q1 25
-57.3%
4.9%
Q4 24
-146.7%
-0.8%
Q3 24
-25.8%
18.9%
Q2 24
-42.4%
6.9%
Q1 24
-80.0%
12.5%
Net Margin
ARCT
ARCT
CPHC
CPHC
Q4 25
-3.1%
Q3 25
-78.4%
2.7%
Q2 25
-32.4%
-2.1%
Q1 25
-47.9%
-2.3%
Q4 24
-131.8%
-10.4%
Q3 24
-16.6%
10.5%
Q2 24
-34.5%
2.1%
Q1 24
-70.5%
7.1%
EPS (diluted)
ARCT
ARCT
CPHC
CPHC
Q4 25
$-0.08
Q3 25
$-0.49
$0.10
Q2 25
$-0.34
$-0.06
Q1 25
$-0.52
$-0.06
Q4 24
$-1.10
$-0.25
Q3 24
$-0.26
$0.40
Q2 24
$-0.64
$0.07
Q1 24
$-1.00
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARCT
ARCT
CPHC
CPHC
Cash + ST InvestmentsLiquidity on hand
$230.9M
$17.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$214.0M
$83.9M
Total Assets
$271.1M
$112.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARCT
ARCT
CPHC
CPHC
Q4 25
$230.9M
$17.1M
Q3 25
$180.4M
$16.7M
Q2 25
$196.5M
$16.9M
Q1 25
$216.9M
$15.4M
Q4 24
$237.0M
$15.1M
Q3 24
$237.2M
$21.7M
Q2 24
$260.3M
$23.8M
Q1 24
$288.4M
$25.2M
Stockholders' Equity
ARCT
ARCT
CPHC
CPHC
Q4 25
$214.0M
$83.9M
Q3 25
$224.6M
$84.1M
Q2 25
$231.1M
$83.6M
Q1 25
$233.8M
$83.7M
Q4 24
$241.0M
$84.1M
Q3 24
$261.9M
$85.2M
Q2 24
$258.6M
$83.2M
Q1 24
$264.0M
$82.7M
Total Assets
ARCT
ARCT
CPHC
CPHC
Q4 25
$271.1M
$112.6M
Q3 25
$282.3M
$114.4M
Q2 25
$309.3M
$114.9M
Q1 25
$331.8M
$112.4M
Q4 24
$344.1M
$109.9M
Q3 24
$370.7M
$114.2M
Q2 24
$388.6M
$111.4M
Q1 24
$418.8M
$105.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARCT
ARCT
CPHC
CPHC
Operating Cash FlowLast quarter
$-74.3M
$-103.4K
Free Cash FlowOCF − Capex
$-74.5M
$-611.3K
FCF MarginFCF / Revenue
-1035.2%
-4.9%
Capex IntensityCapex / Revenue
3.2%
4.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARCT
ARCT
CPHC
CPHC
Q4 25
$-74.3M
$-103.4K
Q3 25
$-17.2M
$1.2M
Q2 25
$-5.8M
$4.4M
Q1 25
$-35.1M
$3.4M
Q4 24
$-284.0K
$-2.8M
Q3 24
$-23.8M
$2.3M
Q2 24
$-30.1M
$5.4M
Q1 24
$-5.6M
$1.6M
Free Cash Flow
ARCT
ARCT
CPHC
CPHC
Q4 25
$-74.5M
$-611.3K
Q3 25
$-17.3M
$-395.3K
Q2 25
$3.2M
Q1 25
$-35.3M
$2.5M
Q4 24
$-6.7M
Q3 24
$-23.8M
$-25
Q2 24
$-30.5M
$1.8M
Q1 24
$-5.8M
$-601.0K
FCF Margin
ARCT
ARCT
CPHC
CPHC
Q4 25
-1035.2%
-4.9%
Q3 25
-101.1%
-2.2%
Q2 25
20.5%
Q1 25
-120.1%
19.1%
Q4 24
-55.9%
Q3 24
-57.2%
-0.0%
Q2 24
-61.1%
11.1%
Q1 24
-15.3%
-4.3%
Capex Intensity
ARCT
ARCT
CPHC
CPHC
Q4 25
3.2%
4.1%
Q3 25
1.1%
9.0%
Q2 25
0.0%
7.5%
Q1 25
0.5%
6.5%
Q4 24
0.0%
32.6%
Q3 24
0.2%
11.8%
Q2 24
0.7%
22.2%
Q1 24
0.6%
15.7%
Cash Conversion
ARCT
ARCT
CPHC
CPHC
Q4 25
Q3 25
2.56×
Q2 25
Q1 25
Q4 24
Q3 24
1.12×
Q2 24
15.95×
Q1 24
1.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARCT
ARCT

Segment breakdown not available.

CPHC
CPHC

Casino$9.5M76%
Other$1.9M15%
Food And Beverage$1.0M8%

Related Comparisons